# US 2023/0404765 A1 · A system and method for osteoarthritis treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0404765 A1
- Document ID: US20230404765A1
- Status: Published application
- Kind: A1
- Application number: 18/251,984
- Filed: 2021-10-07
- Published: 2023-12-21
- Earliest claimed: 2020-12-07
- Assignees: University of Connecticut
- Applicants: University of Connecticut
- Inventors: Thanh Duc Nguyen; Thi Tra Nguyen
- Web page: https://patentgrep.com/patent/US20230404765A1

## CPC

- A61F 2/38: for elbows or knees
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/3654: {Cartilage, e.g. meniscus}
- A61L 27/48: with macromolecular fillers
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/58: Materials at least partially resorbable by the body
- H10N 30/857: Macromolecular compositions
- A61F 2002/2864: {by ultrasonic or acoustic vibrations}
- A61F 2002/30062: {(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive}
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- A61N 2007/0004: {Applications of ultrasound therapy}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- H10N: ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Methods and systems of osteoarthritis treatment. One method includes providing a cartilage hydrogel, the cartilage hydrogel including piezoelectric nano-fibers of Poly-L-lactide (PLLA). The method also includes injecting the cartilage hydrogel into a cartilage defect. The method also includes applying an ultrasonic treatment to the cartilage defect. The method also includes, in response to applying the ultrasonic treatment to the cartilage defect, converting a mechanical impact of the ultrasonic treatment into an electrical charge from the piezoelectric nano-fibers of PLLA and providing, in response to the electrical charge from the piezoelectric nano-fibers of PLLA, chondrogenesis differentiation for cartilage regeneration for the cartilage defect.

## Claims

### Claim 1

A method for osteoarthritis treatment, the method comprising:
providing a cartilage hydrogel, the cartilage hydrogel including piezoelectric nano-fibers of Poly-L-lactide (PLLA);
injecting the cartilage hydrogel into a cartilage defect;
applying an ultrasonic treatment to the cartilage defect; and
in response to applying the ultrasonic treatment to the cartilage defect,
converting a mechanical impact of the ultrasonic treatment into an electrical charge from the piezoelectric nano-fibers of PLLA, and
providing, in response to the electrical charge from the piezoelectric nano-fibers of PLLA, chondrogenesis differentiation for cartilage regeneration for the cartilage defect.

### Claim 2 (depends on 1)

The method of claim 1, wherein applying the ultrasonic treatment to the cartilage defect includes directly applying the ultrasonic treatment to the cartilage defect.

### Claim 3 (depends on 1)

The method of claim 1, wherein providing the cartilage hydrogel includes providing a cartilage hydrogel that includes the piezoelectric nano-fibers of PLLA and a collagen hydrogel.

### Claim 4 (depends on 1)

The method of claim 1, wherein providing the cartilage hydrogel includes providing a cartilage hydrogel that includes the piezoelectric nano-fibers of PLLA and a collagen hydrogel with adipose-derived stem cells.

### Claim 5 (depends on 1)

The method of claim 1, wherein providing the cartilage hydrogel includes providing a cartilage hydrogel that is biocompatible and biodegradable.

### Claim 6 (depends on 1)

The method of claim 1, further comprising:
fabricating the cartilage hydrogel.

### Claim 7 (depends on 6)

The method of claim 6, wherein fabricating the cartilage hydrogel includes electrospinning aligned PLLA nano-fibers.

### Claim 8 (depends on 7)

The method of claim 7, wherein fabricating the cartilage hydrogel includes generating a piezoelectric property of the piezoelectric nano-fibers of PLLA by annealing and stretching nano-fibers of PLLA after electrospinning the aligned PLLA nano-fibers.

### Claim 9 (depends on 1)

The method of claim 1, wherein injecting the cartilage hydrogel into the cartilage defect includes injecting the cartilage hydrogel into the cartilage defect via an arthroscopic procedure.

### Claim 10

A system for osteoarthritis treatment, the system comprising:
a cartilage hydrogel, the cartilage hydrogel including piezoelectric nano-fibers of Poly-L-lactide (PLLA), wherein the cartilage hydrogel is injected into a cartilage defect, and wherein the cartilage hydrogel is configured to receive an ultrasonic treatment at the cartilage defect, and
wherein, in response to the ultrasonic treatment, the piezoelectric nano-fibers of PLLA converts a mechanical impact of the ultrasonic treatment into an electrical charge, wherein the electrical charge triggers a chondrogenesis differentiation for cartilage regeneration for the cartilage defect.

### Claim 11 (depends on 10)

The system of claim 10, wherein the ultrasonic treatment is received directly by the cartilage defect.

### Claim 12 (depends on 10)

The system of claim 10, wherein the cartilage hydrogel includes the piezoelectric nano-fibers of PLLA and a collagen hydrogel.

### Claim 13 (depends on 10)

The system of claim 10, wherein the cartilage hydrogel includes the piezoelectric nano-fibers of PLLA and a collagen hydrogel with adipose-derived stem cells.

### Claim 14 (depends on 10)

The system of claim 10, wherein the cartilage hydrogel is biocompatible and biodegradable.

### Claim 15 (depends on 10)

The system of claim 10, wherein the cartilage hydrogel is fabricated by electrospinning aligned PLLA nano-fibers.

### Claim 16 (depends on 15)

The system of claim 15, wherein the cartilage hydrogel is further fabricated by
generating a piezoelectric property of the piezoelectric nano-fibers of PLLA by annealing and stretching nano-fibers of PLLA after electrospinning the aligned PLLA nano-fibers.

### Claim 17 (depends on 10)

The system of claim 10, wherein the cartilage hydrogel is injected into the cartilage defect via an arthroscopic procedure.

### Claim 18 (depends on 10)

The system of claim 10, wherein the electrical charge is a surface charge that promotes the chondrogenesis differentiation.
